Treatment with the ALT-100 mAb significantly reduced DU145 prostate tumor proliferation to 12.9% ± 1.1% Ki67 proliferative index (p < 0.05) (Figure 2A,C). The gene discussed is MKI67; the disease is prostate neoplasm.